Jul 17, 2026 01:22AM
Jan 9, 2026 09:38AM
Jan 9, 2026 09:36AM
Jun 18, 2025 02:26AM
Jul 15, 2024 01:48AM
Jul 17, 2023 01:36AM
May 23, 2023 11:17PM Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder
Sep 16, 2021 05:37AM
Jun 26, 2021 12:02PM
Jun 15, 2021 06:05PM
Jun 1, 2020 05:52PM
Nov 25, 2019 09:59PM
Nov 7, 2019 10:29PM
Nov 7, 2019 07:00AM Ra Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Aug 7, 2019 07:00AM
Jul 23, 2019 08:10AM
Jun 20, 2019 07:14AM
Jun 4, 2019 03:28AM
May 9, 2019 07:15AM
Apr 9, 2019 09:03AM
Nov 28, 2018 05:07PM Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence
Nov 22, 2018 06:12AM
Jul 16, 2018 02:29AM
Sep 18, 2017 04:17AM
Jul 20, 2017 02:00AM
Jul 12, 2017 09:58AM
Jun 22, 2017 12:00PM
Jun 15, 2017 09:00AM Braeburn Pharmaceuticals and Camurus Announce Presentations of Pivotal Clinical Study Data of Long-acting Buprenorphine
May 2, 2017 04:02AM
May 2, 2017 03:00AM

328,102 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All